Acceleron Pharma

Investors/Media

Press Releases

Date Title and Summary View
Toggle Summary Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference
Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference CAMBRIDGE, MA – March 7, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that Steven Ertel, Vice President Business Development, will provide a corporate
View HTML
Toggle Summary Acceleron Pharma to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
Acceleron Pharma to Present at the Rodman & Renshaw 8th Annual Healthcare Conference CAMBRIDGE, MA – November 3, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company developing regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a corporate
View HTML
Toggle Summary Acceleron Pharma to Present at the MBC’s MASS Opportunities Conference
Acceleron Pharma to Present at the MBC’s MASS Opportunities Conference CAMBRIDGE, MA – October 30, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a
View HTML
Toggle Summary Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic and Anti-Resorptive Properties
Novel Approach Represents Significant Advance for the Treatment of Bone Loss
View HTML
Toggle Summary Acceleron Pharma to Present ACE-011 Preclinical Data at the Annual Meeting of the American Society for Bone and Mineral Research
Preclinical Data Demonstrate Dual Activity of ACE-011
View HTML
Toggle Summary Red Herring: Growing a Backbone; VC’s Finance Bone Loss Treatment
Red Herring: Growing a Backbone; VC’s Finance Bone Loss Treatment Red Herring, August 21, 2006
View HTML
Toggle Summary BioWorld Today: Acceleron Secures $30M in Series B
BioWorld Today: Acceleron Secures $30M in Series B BioWorld Today, August 3, 2006
View HTML
Toggle Summary Acceleron Pharma Closes $30M Series B Financing
Acceleron Pharma Closes $30M Series B Financing CAMBRIDGE, MA – August 2, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, today announced that it secured a $30 million Series B financing.
View HTML
Toggle Summary BioCentury: Acceleron: Value in the Wallflower
BioCentury: Acceleron: Value in the Wallflower BioCentury, July 17, 2006
View HTML
Toggle Summary Acceleron Initiates Phase 1 Clinical Trial of ACE-011, a Novel Treatment for Bone Loss
Acceleron Becomes a Clinical-Stage Company
View HTML